Written answer
Health Services
172. Deputy Maeve O'Connell asked the Minister for Health for an update regarding the implementation of the Model of Care for Lipoedema. [47297/26]
Comment on this
Following endorsement of the Lymphoedema /Lipoedema Model of Care (MOC) by the HSE in early 2019, approval was given by the HSE to move ahead with the planning for the MOC and initiate the implementation of the MOC through a Proof-of-Concept approach. This enabling approach has resulted in 3 Specialist Lymphoedema Clinics (SLC’s) in the community and 3 early detection services in the acute hospitals. The management of lipoedema is an integral part of the role of the current Specialist Lymphoedema Clinics. The Proof-of-Concept services are funded on a temporary year to year basis.
Funding in respect of all 3 of the current SLC’s and early detection services are continuing in 2026.
The HSE established the National Lipoedema Working Group in 2023. This group was tasked with developing a guideline for the diagnosis and management of lipoedema. The guideline has now been completed and focuses on diagnosis and non-surgical management. The guideline was developed following a review of the available research and expert consensus. It notes that the diagnosis and treatment of lipoedema remain an evolving area, with limited definitive evidence available. The guideline will be updated as new evidence emerges.
It also recommends a range of evidence-based treatments, including physical activity, weight management support, physiotherapy where appropriate, compression garments for symptom control, and psychosocial supports.
In terms of improving access to care, the HSE developed the guideline, a patient information booklet and education support for healthcare professionals and membership of the working group also included service users from the Lipoedema Association of Ireland throughout its development.
Surgical management of lipoedema i.e. liposuction, was not included in the clinical guideline for the diagnosis and non-surgical management of lipoedema as the role of liposuction was still under review by the HSE at the time of concluding the guideline.
More broadly, the HSE continues to develop lymphoedema services through specialist community clinics and early detection services. These initiatives have demonstrated improvements in patient outcomes, reduced hospitalisations and improved access to care.
The HSE will continue to review emerging evidence and support people living with lipoedema through evidence-based services and clinical guidance.